LINNEA® NEWS


Stay informed and inspired with the latest health news and insights on Linnea

December 16th 2025

Patent granted: Advancing innovation in…

We are proud to announce that our products have been granted a patent by…

Read More

December 1st 2025

ESG Policy 

Effective from 1 December 2025  Linnea releases its updated Environmental Social & Governance (ESG)…

Read More

October 15th 2025

Scientific breakthrough from Linnea and…

We’re proud to announce the first-ever isolation of a previously unknown cannabinoid, cannabizetol (CBGD),…

Read More

October 8th 2025

Milestone achieved – 6 month…

We are proud to announce that our THC:CBD combinations have reached 6-month ICH stability.…

Read More

October 3rd 2025

Human Rights (HR) Policy

Effective from 3 October 2025  Our updated Human Rights Policy 2025 is now live,…

Read More

September 17th 2025

A major milestone achievement: THC…

We are thrilled to announce that Linnea’s GMP certificate just got a major upgrade…

Read More

July 21st 2025

Upholding principles through responsible business

Last week, we took another important step forward by submitting our updated Communication on…

Read More

July 7th 2025

Decarbonization in action: Linnea’s 2025…

We are pleased and proud to announce that our company’s Decarbonization plan has been…

Read More

June 2nd 2025

A new chapter in Linnea’s…

The installation of our new THC distillation unit marks a major milestone in bringing…

Read More

May 25th 2025

The power of the Cannabis…

Following our previously published findings on the anti-inflammatory potential of CBD-rich extracts in psoriasis…

Read More

May 23rd 2025

Cannabigerol – driven innovation: towards…

Exciting developments are underway in the world of nanomedicine, as researchers unveil a pioneering…

Read More

April 15th 2025

Shaping the Future of Cannabis…

After giving its contribution to the revision of the Ph. Eur. monograph on Cannabis…

Read More

March 31st 2025

Vivalto Partners announces the 100%…

Vivalto Partners, a French private equity firm dedicated to healthcare, is pleased to announce…

Read More

March 14th 2025

Linnea participates in the AGRIHEALTH…

Linnea is proud to announce its participation as the Swiss frontrunner partner in the…

Read More

November 22nd 2024

Setting a Global Standard: Linnea’s…

Linnea SA has been a pioneer in the Cannabinoid active pharmaceutical ingredient (API) industry…

Read More

October 17th 2024

LINNEA AT CPHI MILAN–2024 EDITION

In October 2024, Linnea team was thrilled to exhibit at CPHI Milan, the premier…

Read More

July 5th 2024

Linnea’s Vincamine obtains a CEP…

The European Directorate for the Quality of Medicines & Healthcare (EDQM) has issued a…

Read More

May 14th 2024

Linnea is compliant with the…

Linnea is proud to comply with the new CBD monograph issued by the European…

Read More

March 31st 2021

Code of Conduct

Effective from March 2021 Linnea reaffirms its commitment to strong ethical standards, responsible behavior,…

Read More

Education, Community and Thought Leadership


Linnea goes beyond manufacturing to support our customers, connect with the community, and educate worldwide about the potential therapeutic benefits of our ingredients

Get the latest
Linnea® news